Recombinant Adeno-Associated Viral Vectors

7Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Recombinant adeno-associated viral (rAAV) vectors can be used to locally or systemically enhance or silence gene expression. They are relatively nonimmunogenic and can transduce dividing and nondividing cells, and different rAAV serotypes may transduce diverse cell types. Therefore, rAAV vectors are excellent tools to study the function of neuropeptides in local brain areas. In this chapter, we describe a protocol to produce high-titer, in vivo grade, rAAV vector stocks. The protocol includes an Iodixanol gradient, an anion exchange column and a desalting/concentration step and can be used for every serotype. In addition, a short protocol for rAAV injections into the brain and directions on how to detect and localize transduced cells are given.

Cite

CITATION STYLE

APA

de Backer, M. W. A., Garner, K. M., Luijendijk, M. C. M., & Adan, R. A. H. (2011). Recombinant Adeno-Associated Viral Vectors. In Methods in Molecular Biology (Vol. 789, pp. 357–376). Humana Press Inc. https://doi.org/10.1007/978-1-61779-310-3_24

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free